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ABSTRACT
Genomic imprinting refers to a specialized form of
epigenetic gene regulation whereby the expression
of a given allele is dictated by parental origin.
Defining the extent and distribution of imprinting
across genomes will be crucial for understanding
the roles played by imprinting in normal mammalian
growth and development. Using mice carrying
uniparental disomies or duplications, microarray
screening and stringent bioinformatics, we have
developed the first large-scale tissue-specific
screen for imprinted gene detection. We quantify
the stringency of our methodology and relate it to
previous non-tissue-specific large-scale studies. We
report the identification in mouse of four brain-
specific novel paternally expressed transcripts and
an additional three genes that show maternal expres-
sion in the placenta. The regions of conserved
linkage in the human genome are associated with
the Prader–Willi Syndrome (PWS) and Beckwith–
Wiedemann Syndrome (BWS) where imprinting is
known to be a contributing factor. We conclude that
large-scale systematic analyses of this genre are
necessary for the full impact of genomic imprinting
on mammalian gene expression and phenotype to
be elucidated.
INTRODUCTION
Genomic imprinting refers to a specialized form of epigenetic
gene regulation whereby the expression of a given allele
is dictated by its maternal versus paternal origin. Imprint-
ing plays a crucial role in mammalian reproduction and
imposes an absolute requirement for maternal and paternal
genomes for the generation of viable offspring (1,2).
Approximately 80 imprinted genes have been identiﬁed in
mouse (http://www.mgu.har.mrc.ac.uk/research/imprinted/),
and around 40 in human (3). The extent of imprinting in
mouse or human is not fully known, but has been estimated
in mouse to range between 100 and 600 genes (4–6). Mis-
regulation of the imprinted genes has been associated with
growth and developmental abnormalities in mice (1,2,4),
birth defects (7,8) and neoplasias in humans (9) as well as
abnormalities in cloned mammals (10,11).
The rationale for the identiﬁcation of new imprinted genes
is based on further understanding imprinted gene regulation
and the genetic components of developmental phenotypes
in the mouse and birth defects in humans, such as Prader–
Willi Syndrome (PWS), Beckwith–Wiedemann Syndrome
(BWS) and cancer. Imprinted genes are frequently associated
with asynchronous DNA replication (12) and epigenetic con-
trol mechanisms that can extend over large genomic regions.
Studying aspects of epigenetic regulation requires examina-
tion of the genomic environment, especially in cases of
placenta-speciﬁc imprinting where evidence suggests that
not only DNA methylation but also histone modiﬁcation is
important for imprinted gene expression (13,14). Thus an
inventory of monoallelic expression of genes and transcripts
in a given region is advantageous.
Imprinted genes are characteristically differentially
expressed in mice with a maternally derived uniparental
duplication or disomy (matUpDp/UpD) compared to mice
where the same UpDp/UpD is of paternal origin (patUpDp/
UpD). Ideally, expression of an imprinted gene transcribed
from the maternally inherited allele will increase 2-fold in
a matUpDp sample compared to wild-type (wt) and will be
undetectable in a patUpDp sample, and vice versa. In con-
trast, the expression of a non-imprinted gene is not expected
to differ. Strains of mice carrying reciprocal and
Robertsonian translocation chromosomes have been used to
produce progeny where both copies of a particular chromo-
some or chromosomal region have been inherited from only
the mother or the father. Here, the reciprocal translocation
mouse strain T65H (15) was used to generate progeny
with UpDps of Chromosomes (Chrs) 7 and 11 either proximal
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viously (16). These mice provide the basis for both the com-
putational and molecular studies presented here. They are
viable until birth, so that differential gene expression pro-
ﬁles over a range of different tissues were investigated.
Robertsonian translocation mouse strains that generated
UpDs of Chr 18 (17) and Chr 12 (18) were used to gain addi-
tional statistical power for the evaluation of this method.
To a limited degree, the effectiveness of this method has
already been demonstrated by the identiﬁcation of a novel
brain-speciﬁc imprinted gene, Inpp5f_v2 (19). Here, we report
on the results of systematically reﬁning our approach and
extending its coverage to the whole of Chr 7 and Chr 11.
We describe this methodology, quantitatively evaluate its
effectiveness and compare it to previous non-tissue-speciﬁc
whole genome studies, reviewed in (20). This study has iden-
tiﬁed and validated four novel brain-speciﬁc paternally
expressed transcripts and three placenta-speciﬁc maternally
expressed genes.
MATERIALS AND METHODS
Tissue sources
Mouse: the tissue sources for the T65H translocation strain
are described in (16). Essentially, newborn mice with mater-
nal and paternal duplications for speciﬁc regions of Chrs 7
and 11 were generated using the T65H translocation
(21,22). The tissues selected are shown in Table 1 and include
13.5 dpc embryo and placenta, newborn brain, carcass, heart
and liver for matUpDp prox 7 versus patUpDp prox 7 (the
same samples also generate data for patUpDp prox 11 versus
matUpDp prox 11). MatUpDp distal 7 samples were com-
pared to normal sibling samples at 13.5 dpc since the
patUpDp distal 7 embryo is not viable at this stage of devel-
opment. 8.5dpc embryos with maternal versus paternal
UpD for Chr 18 were also compared using a Robertsonian
translocation Chr Rb(2.8)2Lub(7.18)9Lub or RB92.82Lub
(R) and C57BL/6JEi-Rb(7.18)9Lub (B) strains obtained
from the Cytogenetic Models Resource at the Jackson Labor-
atory (17). Placentae were dissected free from the decidua.
However, due to the structure of the placenta with invading
maternal vessels, some maternal material is likely to be
included in these preparations. 15.5 dpc embryos and placen-
tae from Chr 12 UpD (18) were obtained in collaboration
with Anne Ferguson-Smith. Human: for DHCR7 and
AMPD3, anonymous placenta DNA and RNA samples were
collected in collaboration with Dr B.S. Emanuel (CHOP) in
accordance with ethical guidelines.
Microarray protocols
Affymetrix Genechips  U74v2 and 430v2 microarrays were
used (Table 1). The U74v2 triple array series represents
 36000 genes and ESTs. The U74v2 series represents all
sequences ( 6000) in the Mouse UniGene database (Build
74) that had been functionally characterized at the time
plus EST clusters. The 430v2 dual array series probes
 39000 genes and ESTs where the 430Av2 array predomi-
nantly represents well-characterized genes.
Caesium chloride isolated total RNA from samples in
Table 1 were quantiﬁed on an Agilent Bioanalyser  and
5–7 mg was used to prepare biotin-labelled cRNA target
essentially as in the Affymetrix  expression manual (23).
Biotinylated cRNA targets were puriﬁed using cRNA
Cleanup spin columns (Affymetrix ), fragmented in 5· frag-
mentation buffer (Affymetrix ), and quantiﬁed prior to
hybridization on an Agilent Bioanalyser . A total of
0.15 mg of labelled probe was hybridized per GeneChip
expression array followed by washing and staining on the
Affymetrix  ﬂuidics station 450. An Affymetrix Scanner
3000 was used to quantify the signal.
Gene chip operating software (GCOS) data analysis
Data from the scanner were analysed using the Affymetrix 
MASv5 or GCOS software. The software computes the signal
for each pair of corresponding PM and MM probes in a probe
set as Si ¼ log2(PMi)   log2(MMi) where PMi and MMi are
the measured ﬂuorescence levels of the ith probes in the PM
and MM sets. In cases where Si would barely exceed the
background noise level or be negative, GCOS makes adjust-
ments to ensure a conservative and positive estimate of gene-
speciﬁc hybridization. GCOS arrives at a single signal value
(S) for each probe set by calculating the Tukey-biweight of
the Si, a weighted outlier-resistant average. GCOS reports
2
S as the estimate of the absolute expression level of the
gene represented by the probe set. GCOS allows a compara-
tive analysis of gene expression in two samples, each used to
hybridize a separate microarray. GCOS computes a signal
log2-ratio (SLR) for each probe set as a measure of the degree
of differential expression between the two samples and a
P-value as a measure of conﬁdence in any measured differ-
ence in expression. In the most common case, the SLR equals
the Tukey-biweight over i of log2(APMi)   log2(AMMi)  
[log2(BPMi)   log2(BMMi)]; where APMi, e.g., is the mea-
sured ﬂuorescence of the ith PM probe in a particular probe
set on array A (hybridized with sample A). The P-value is
based on a Wilcoxon signed rank test applied to the pairs
of differences [log2(APMi)   log2(AMMi), log2(BPMi)  
log2(BMMi)] and [log2(APMi)   A, log2(BPMi)   B], where
Table 1. Overview of the microarray data used in this study
UpDp/UpD Microarray Tissue
Series Model Pl Em Cc Br Lr Ht
Prox Chrs
7 and 11
Affymetrix  Ax x
430v2 B x x
Affymetrix  Ax x x x
U74v2 B x x x x
Cx x x
Incyte  GEM 1 x x x
Dist Chrs
7 and 11
Affymetrix  Ax x
U74v2 B x x
Cx x
Chr 12 Affymetrix  Ax x
U74v2 B x x
Cx x
Chr 18 Affymetrix  Ax
430v2 B x
An ‘x’ indicates the availability of data for a specific combination of UpDp/
UpD, microarray and tissue (Pl ¼ placenta, Em ¼ embryo, Cc ¼ carcass,
Br ¼ brain, Lv ¼ liver and Ht ¼ heart). Note that for the experiment using
a prox Chrs 7 and 11 sample of heart, there was only enough material to
hybridize the U74v2 A and B arrays.
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tive array.
Expression analysis
Two assays were used; the ﬁrst used cDNA prepared from
maternal and paternal UpDp and wt RNA samples in
RT–PCR assays. Brieﬂy, 4 mg of total RNA was reverse tran-
scribed using Superscript III (Invitrogen ) reverse transcrip-
tase (manufacturers’ instructions) and PCR-ampliﬁed using
ABgene  Reddymix and gene-speciﬁc primers (Supplemen-
tary Table S4). The second method used inter-subspecies
hybrid RNA as described in (19). Essentially, single nucleot-
ide polymorphisms (SNPs) between Mus m. musculus
[C57Bl6J (B6)] and Mus m. castaneus (CAST) strains were
identiﬁed and assayed by DNA sequencing (primers are listed
in Supplementary Table S4). RT–PCR followed by sequenc-
ing identiﬁed the expressing allele(s) for each gene tested
(Figures 2 and 3). Sequencing was performed on an ABI
3730 DNA analyser using ABI BigDye  reagents (manufac-
turer’s protocols). Fetal or parental human DNAs were
sequenced for expressed SNPs, which were assayed as
described above.
Gene prediction programs
Gene predictions tools used include Ensembl (24–26). SGP
(27), Geneid (28), Genscan (29), Superfamily/SCOP (30),
Twinscan (31) and Augustus (32).
RESULTS
The ‘one chromosome at a time’ approach excludes
most false positives
Each of the microarrays used here measures the expression of
thousands of distinct transcripts, all of which can potentially
change in expression levels between the respective matUpDp/
UpD and patUpDp/UpDs. However, most transcripts can be
ruled out based on their location within the genome that
places them outside the selected chromosomal duplication
or disomy.
Four chromosome anomalies were investigated (Table 1).
Filtering by genomic position reduced the number of poten-
tial false positives by between 85 and 94% (Table 2). For
example, of the 45037 distinct non-control probe sets, repre-
senting over 39000 transcripts, on the Affymetrix  430v2
arrays, only 6595 (14.6%) generate a match to proximal
Chrs 7 or 11 when their target sequences are aligned with
the genome (March 2005 NCBI build 34) using BLAT
(33). The remaining 38442 probe sets do not pass the hence-
forth called ‘map ﬁlter’ for this UpDp and thus can be
excluded from the search. On average, about a tenth of the
transcripts represented on the microarrays mapped to the
respective region of UpDp/UpD in our experiments and
could legitimately change in expression between the
matUpDp/UpD and pat UpDp/UpD samples as a direct result
of being imprinted. This reduction of potential false positives
by an order of magnitude compared to the analogous whole
genome approach (parthenogenote versus androgenote), is
compounded by the more limited downstream effects of
UpDp/UpDs.
Gains in sensitivity by combining differential
expression measures
Arrays hybridized with the matUpDp/UpD sample were com-
pared to arrays hybridized with the patUpDp/UpD sample
using the gene operating software (GCOS) that provides
two measures of differential expression (34). The SLR of a
probe set captures the fold change in expression of the repre-
sented transcript between the two samples, i.e., in simpliﬁed
terms, SLR ¼ log2(expression in matUpDp/UpD / expression
in patUpDp/UpD). In addition, GCOS supplies a P-value that
expresses the conﬁdence in and direction of any measured
expression difference, that is, P ¼ 0.5 if there is no evidence
for a change in expression, and P is the closer to 0 or 1 the
more statistical evidence there is for an increase or decrease
in expression, respectively.
SLR and P-value are closely correlated but non-redundant
measures. Frequently, a probe set’s absolute SLR (jSLRj)i s
large while 0.5  j P   0.5j 0.5, meaning that while a
large fold change is measured, there is little statistical evi-
dence for differential expression. The converse happens simi-
larly frequently. Which of the two measures more truthfully
represents the actual degree of differential expression is not
immediately clear. Previously, SLR and P-value have been
shown to give qualitatively different results (35). Here, we
systematically evaluated the performance of SLR, P-value
and combinations of both, namely, P-value-weighted SLRs
(xSLR), in the context of imprinted gene detection. Speciﬁc-
ally, xSLR ¼ 0 if 0.5  j P   0.5j > x, and otherwise,
xSLR ¼ [1   1/x (0.5  j P   0.5j)] SLR. Within the interval
Table 2. For each combination of microarray series, UpDp/UpD and tissue (Pl ¼ placenta, Em ¼ embryo, Cc ¼ carcass, Br ¼ brain, Lv ¼ liver and Ht ¼ heart)
used in this study, the table shows the number of distinct non-control probe sets detecting differential expression that map to within (normal script) versus to only
outside (italic script) the UpDp/UpD
UpDp/UpD: Prox Chrs 7 and 11 Dist Chrs 7 and 11 Chr 12 Chr 18
Array series Number of distinct non-control probe sets
Mapping to within (normal) verus to only outside (italic) the UpDp/UpD
Total Total luSLR| > 6 Total luSLR| > 6 Total luSLR| > 6 Total luSLR| > 6
Pl Em Cc Br Lv Ht Pl Em Pl Em Em
430 45037 6595 222 212 3852 245
38442 1321 1084 41185 2246
U74 36701 3679 161 305 325 125 3157 107 101 2240 58 267
33022 1227 2451 2650 854 33544 1128 1321 34461 603 4369
The table also provides the total number of non-control probe sets per microarray series and, for each UpDp/UpD in turn, the total number of probe sets that map to
within versus to only outside the UpDp/UpD.
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zero where it remains at all lower levels of statistical conﬁ-
dence. We explored the whole range of possible values for
x, i.e. 0 < x < 0.5, and found x ¼ 0.01 (uSLR) to perform
best, closely followed by x ¼ 0.05 (vSLR). The simple linear
weighing of SLR over the whole range of P-values, (x ¼ 0.5;
pSLR) was not nearly as effective.
For each measure, we ﬁrst estimated from our microarray
data, the true positive rate (TPR) and false positive rate
(FPR) for a range of differential expression thresholds.
The TPR was estimated from a total of 43 known imprinted
genes that map to within the investigated UpDp/UpDs and
for which there are representative probe sets. For each tis-
sue, we counted (a) the number of genes within the respec-
tive UpDp/UpD that the literature has reported to be
imprinted in the tissue and for which tissue-matched array
data were available and (b) the number of such genes for
which in addition, at least one representative probe set
detected an increase (for maternally expressed genes) or
decrease (for paternally expressed genes) in expression that
met or exceeded the differential expression threshold. The
TPR was computed as the ratio between the two sums
over all tissues of counts (b) and (a). The FPR is the fraction
of probe sets mapping to the investigated UpDp/UpDs that
do not represent known imprinted genes but nevertheless
met or exceeded the differential expression threshold. Plot-
ting the FPR versus the TPR over the range of decision
thresholds yields a receiver operating characteristics (ROC)
curve shown for SLR, P-value, uSLR, vSLR and pSLR
(Figure 1).
A low FPR is paramount to achieve a good cost to discov-
ery ratio in the molecular validation. Even with the map ﬁlter,
an FPR of 5% still corresponds to, in the proximal Chrs 7 and
11 region, roughly 300 distinct probe sets on the 430 array
that will be ﬂagged as representing differentially expressed
sequences, but are unlikely to represent imprinted transcripts.
We therefore chose 5% as the upper limit on the FPR. Up to
this limit, uSLR consistently performed best, i.e. gave the
highest TPR compared to the other measures that we consid-
ered. Consequently, the ROC curve for uSLR dominates the
other curves in Figure 1 for an FPR < 5%. Speciﬁcally, the
differential expression threshold of juSLRj > 0.6 delivered
a TPR ¼ 65.8% and an FPR ¼ 4.9% so that henceforth,
‘differentially expressed’ will imply juSLRj > 0.6.
The map filter saturates candidates
with imprinted genes
To prioritize the molecular validation experiments, we ranked
the probe sets passing the map ﬁlter by degree of differential
expression, i.e. in descending order of juSLRj. On average,
19% (29%, 38%, 46% and 52%) of all genes known to be
imprinted in the respective tissue and mapping to within
the respective duplication were ranked among the top 10
(20, 50, 100 and 200). Compared to the analogous ranking
of all probe sets, i.e. without the prior application of the
Figure 1. ROC curves for the SLR (solid), P-value (dashed), pSLR (finely dashed), uSLR (dotted) and vSLR (dash-dotted) differential expression measures.
Each curve shows the TPR y-axis in relation to the FPR x-axis, estimated at various different decision thresholds for the respective measure and linearly
interpolated in between the estimates. Labelled arrows point out thresholds of particular importance, specifically, the thresholds at which the estimated FPR was
roughly 5% for all five measures, and/or, for uSLR and vSLR, thresholds that marked the end of steep increases in the TPR and therefore constituted particularly
good trade-offs between TPR and FPR. The legend in the figure states for each measure the condition that a probe set needed to satisfy in order to be considered
differentially expressed where r, s, t, u and v are the decision thresholds, and P and SLR are the P-value and SLR as computed by GCOS. d denotes Kronecker-d,
that equals 1 if the boolean expression in parenthesis (in our case unequality) is true, and that equals 0 otherwise. The uSLR consistently achieved the highest
TPR for up to an FPR of 5%, closely followed by vSLR. Most significantly, P-value and SLR in isolation performed much worse as measures of differential
expression than when combined in measures like uSLR.
e88 Nucleic Acids Research, 2006, Vol. 34, No. 12 PAGE 4 OF 12map ﬁlter, this corresponds to an average increase in the num-
ber of known imprinted genes in the top 10 (20, 50, 100 and
200) ranks by 85% (71%, 57%, 61% and 48%). Table 3
provides the absolute values. This illustrates how the map
ﬁlter increases the saturation of the top ranks with known
imprinted genes and, by extrapolation, with likely truely
imprinted candidate genes.
Summary statistics of probe sets representing
differentially expressed sequences
Table 2 gives a complete account, broken down by UpDp/
UpD, tissue and microarray series, of how many probe sets
whose target sequences map to within versus to exclusively
outside the UpDp/UpD detected differential expression. On
average, 4.9% (5.3%) of the probe sets mapping to within
(outside) the UpDp/UpD detected differential expression.
The differences underlying these averages are not statistically
signiﬁcant (P ¼ .083; Wilcoxon signed rank test), which
suggests that proportionately and in terms of differential
expression, a UpDp/UpD affects the region of duplication
approximately as much as the rest of the genome.
Differential gene expression profiles across tissues
For the UpDp of proximal Chrs 7 and 11, we conducted sepa-
rate microarray experiments using placenta, embryo, carcass,
brain, liver and heart samples (Table 1). Thus, we created
tissue-speciﬁc differential expression proﬁles. Only limited
or no tissue-speciﬁc data were available for the distal UpDp
of Chrs 7 and 11 and the UpDs of Chrs 12 (embryo and
placenta) and 18 (embryo).
Proﬁles of 43 known imprinted genes on Chrs 7, 11, 18 and
12 are compared with the literature-reported imprinting status
in Supplementary Table S1. Proﬁles of the 59 genes on Chrs
7 and 11 that were not known to be imprinted and for which
we conducted imprinting validation experiments are listed in
Supplementary Table S2, where the results of the validation
assays appear side-by-side with the microarray data. The
proﬁles of all transcripts on proximal Chrs 7 and 11 (935 tran-
scripts represented by 1705 probe sets) that were differenti-
ally expressed in at least one of the tissues are shown in
Supplementary Table S3.
Confirmation of seven differentially
expressed candidates
Allele-speciﬁc assays using UpDp/UpD RNAs have been
used extensively to determine parent of origin speciﬁc gene
expression (36), but could be argued not to be independent
of the microarray assay since the starting material is the
same (37). Interspecies hybrids have been used to assay for
parent of origin speciﬁc expression (38–40) but loss of
imprinting of some genes has been detected in hybrid crosses
(41). So, where possible we have used more than one method.
Moreover, we have tested known imprinted genes and have in
every case conﬁrmed imprinting status.
A set of 59 candidate genes with an unknown imprinting
status were selected and initially screened in an RT–PCR
approach using matUpDp versus patUpDp RNA templates
(where available). Candidates showing evidence of parental
origin speciﬁc expression in this assay on the proximal
regions of mouse Chrs 7 were subjected to further validation
using RT–PCR combined with a SNP allele-speciﬁc assay in
mouse inter-sub-speciﬁc hybrids.
On proximal Chr 11 in whole embryo or isolated brain,
eight candidate imprinted transcripts were tested for monoal-
lelic expression by RT–PCR in mat versus patUpDp material
(Supplementary Table S2), along with two control known
imprinted genes, U2af1-rs1 and Grb10. The control genes
showed imprinted expression and six out of eight non-control
genes were biallelic. Pnpt1 was expressed in paternally dupli-
cated samples only but was not present in wt, Gabra1 showed
some maternal bias, but this difference was not considered
robust enough to warrant further study. Lsm11 is located
within band B1.1 of Chr 11 containing the T65H transloca-
tion breakpoint thus may have been duplicated in the distal
rather than the proximal experiment. However, the distal
microarray data did not suggest differential expression of
Lsm11.
On proximal Chr 7, 25 transcripts were tested for monoal-
lelic expression in brain, 17 in whole embryo, 5 in placenta
and 2 in heart (Supplementary Table S2). By UpDp assay,
10 transcripts showed allele bias in brain and were tested fur-
ther by SNP analysis, which conﬁrmed that four of these
(BB077283, BM117114, AK080843 and AV328498) were
paternally expressed (Figure 2). BB182944 and BB312372
were also validated as paternally expressed but were subse-
quently found to correspond to the imprinted Pec2 and
Pec3 transcripts (42) and were excluded. Of the remainder,
Ampd3 was maternally expressed in placenta. The placenta
UpDp assay showed a maternal bias with some paternal
expression (data not shown) rather than the exclusive mater-
nal expression seen with the interspecies SNP assay
(Figure 3). BB264453 was robustly differentially expressed
Table 3. For each combination of tissue (Pl ¼ placenta, Em ¼ embryo, Cc ¼
carcass, Br ¼ brain,Lv ¼ liverand Ht ¼ heart) and microarray series, the table
first shows the union of the respectively studied UpDp/UpDs, then the total
number of known imprinted genes located within the corresponding genomic
regions, and finally, the number of known imprinted genes for which probe
sets ranked in the top 10, 20, 50, 100 and 200, respectively, when the probe
sets on all arrays of the series were arranged in descending order of |uSLR|,
with (normal script) and without (italic script) prior application of the map
filter.
Tissue Array
series
Union of UpDp/UpDs Numberofknownimprintedgenes
Total Ranked in top ...
10 20 50 100 200
Br 430 Prox Chrs 7 and 11 20 4 6 10 11 13
36 791 1
Cc U74 Prox Chrs 7 and 11 12 4 5 6 6 7
23 45 6
Em 430 Prox Chrs 7 and 11,
Chr 18
21 3 7 8 12 12
36 77 9
U74 Dist Chrs 7 and 11,
Chr 12
1 9 34 45 6
11 23 3
Ht U74 Prox Chrs 7 and 11 10 4 5 5 6 6
23 45 5
Lv U74 Prox Chrs 7 and 11 12 2 2 3 5 5
11 22 3
Pl U74 Chrs 7 and 11, Chr 12 31 4 7 11 13 16
11 45 7
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tain a SNP between B6 and cast and so was not considered
further. The location of AI114950 within band F4 of Chr 7
makes it analogous to Lsm11 and the distal microarray data
did not suggest differential expression of AI114950. The
remaining tested transcripts were biallelic by SNP assay.
AK080843 and AV328498 are transcribed in the
antisense orientation relative to Ube3A and could be part of
the large imprinted antisense transcript LNCAT, (43,44) but
because the LNCAT cDNA is not clearly deﬁned or publicly
available, this is uncertain.
Ten transcripts were selected from distal mouse Chr 7
(Supplementary Table S2). Of these, Th and Dhcr7 were
maternally expressed in placenta (Figure 3) but were biallelic
in embryo. These transcripts were not as robustly monoal-
lelic as the novel brain transcripts in the proximal region,
although the allele preferences exchanged with reversed
parental transmission (Figure 3).
Figure 2. Identification of novel paternally expressed transcripts on mouse proximal Chr 7. (A) The 2 Mb PWS/AS orthologous region with positions of
the novel paternally expressed transcripts indicated*. Genes are shown as open boxes with the relative transcriptional orientations defined by arrows. Blue, red
or no colouring define paternal, maternal or biallelic expression respectively. (B) RT–PCR analysis of candidates identified on the proximal Chr 7 brain array
in cDNA derived from patDp prox 7, matDp prox 7 and wild-type brain tissue. Controls for paternal (Snrpn), maternal (Grb10) and biallelic (Igf1r) expression
are shown. The molecular weight marker is a 100 bp DNA ladder where the bright band corresponds to 500 bp. Samples treated with and without
reverse transcriptase are indicated as + or  RT. ESTs AK080843, BB077283, BM117114 and AV328498 were paternally expressed. (C) Allele-specific
RT–PCR analysis of proximal Chr 7 candidates. Newborn brain tissues with expressed SNPs were obtained from reciprocal crosses between M.m.musculus
(B6) and M.m.castaneus (CAST) animals. cDNA fragments containing the SNPs were recovered by RT–PCR and direct sequencing to determine allele-
specific expression.
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and genomic context
Gene predictors were applied to the genomic regions con-
taining the ESTs for which validation by RT–PCR and SNP
analysis had conﬁrmed imprinting (Figure 2). The genomic
position of each EST was uniquely identiﬁable. In brain
and embryo, the paternally expressed AK080843 and
AV328498 map to a region between 6.7 and 13 kb cen-
tromeric of Snrpn (Figure 2A). Based on the genomic
sequence of this region, no prediction program provided evi-
dence for a separate gene or an extended transcript of Snrpn
whose coding region aligns with the ESTs. AV328498 is the
30-read of the full insert sequence AK078094 that partially
overlaps AK080843. Both AK078094 and AK080843 par-
tially overlap BC070450, a transcript extending much further
30. The distinct splicing patterns of these transcripts suggest
that they might be alternative transcripts of the same tran-
scriptional unit. Whether these transcripts are extensions of
Snrpn is not completely clear but based on the ESTs in the
region (including AK080843 and AV328498, AK078094),
Ensembl predicts a gene (ENSMUSG00000016158) that is
distinct from Snrpn at this location. To further ascertain
whether transcripts AV328498 and AK080843 could splice
Figure 3. Identification of novel maternally expressed transcripts on mouse distal Chr 7. (A) The  1 Mb BWS orthologous region shown with positions of the
novel maternally expressed genes indicated*. Regions of conserved linkage on human chromosomes are indicated by horizontal bars. Genes are shown as open
boxes with the relative transcriptional orientations defined by arrows. Blue, red or no colouring define paternal, maternal or biallelic expression respectively. (B)
Allele-specific RT–PCR analysis of distal Chr 7 candidates. Embryo and placenta (E13.5) tissues with expressed SNPs were obtained by performing reciprocal
crosses between M.m.musculus (B6) and M.m.castaneus (CAST) animals. cDNA fragments containing the SNPs were recovered by RT–PCR then direct
sequenced to determine allele-specific expression. Distal Chr 7 candidates; Dhcr7, Th and Ampd3 were maternally expressed in E13.5 placenta (lower panels) but
biallelic in E13.5 embryo (middle panels). Ubiquitously imprinted (H19) and biallelic (Tnnt3) control genes are shown.
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AV328498 and AK080843 reverse primers (Supplementary
Table S4, SNP assay primers) to amplify brain cDNA by
RT–PCR. ABGene thermoprime plus Taq polymerase was
used to amplify large products of up to 12 kb. No products
were seen from any primer combination (data not shown).
This provides empirical data to support these transcripts
being independent of Snrpn, but they are limited in assaying
the absence of a product. Similarly, no genes were predicted
that coincide with BB077283 (corresponding 50-read:
BB625859) or BM117114 (no 50-read available, but identical
to BQ555876 with corresponding 50-read BQ555877). These
ESTs map telomeric of Snrpn and centromeric of Ndn
(Figure 2A) and are located distant (1.8 Mb; BM117114
and 1.3 Mb; BB077283) from Snrpn and hence are not likely
to be part of the Snrpn transcript.
Human orthologues of mouse distal Chromosome 7
genes are not maternally expressed in placenta
We examined the expression status of the human orthologues
DHCR7 and AMPD3 in placenta using a combined RT–PCR
and SNP assay essentially as performed in the mouse tissues.
Both genes were biallelically expressed in human term pla-
centae (Figure 4). The imprinting status of TH was not
addressed, since informative polymorphisms could not be
found in our sample sets. These genes may however be
imprinted in other non-tested human tissues since tissue-
speciﬁc imprinting need not be the same between
species (45).
Limited overlap with previous non-tissue-specific whole
genome imprinting studies
A 2-fold change in expression was used as the cut-off for dif-
ferential expression in RIKEN’s FANTOM2 imprinting screen
(46), which identiﬁed 2110 imprinting candidate transcripts. A
large fraction of these transcripts were represented by probe
sets on the Affymetrix  arrays (430v2: 79%, U74v2: 65%),
and between 17 (350) and 41% (870) of them were represented
by probe sets mapping to one of the investigated UpDp/UpDs.
Given that the above transcripts constitute imprinting candi-
dates, we expected a large fraction of them to be represented
by one or more differentially expressed probe sets in our
experiments. However, at the most, this fraction was 45%
(UpD of Chr 18), and across all UpDp/UpDs, tissues and
microarray series’, the average was 20.4%. The overlap
between the RIKEN imprinting candidates and differentially
expressed probe sets in our experiments increased when a
less stringent differential expression threshold was used, per-
mitting a higher FPR. For example, using jpSLRj > 0.5 with
a TPR of 74% and an FPR of 21.1% (Figure 1), the overlap
increases to 66.6% in the best case (UpD of Chr 18), and to
50.3% on average. This suggests that the juSLRj > 0.6 is
more stringent than the 2-fold change in expression threshold
used in the RIKEN study.
Recent work that used bioinformatic methods predicted
600 out of 23 788 annotated (Ensembl) autosomal mouse
genes to be imprinted based on their similarity to sequence
features surrounding 44 known imprinted genes, and their
dissimilarity to  500 assumed non-imprinted genes (6).
The TPR and FPR of the analysis, determined by cross-
validation, was 100 and 7%, respectively. Using the same
method, the authors also predicted allele preference, that
cross-validation showed to be 97.7% accurate. We observed
the largest overlap with our study on proximal Chrs 7 and
11 to which 27 of the 600 predicted imprinted genes mapped
and were represented by probe sets on the Affymetrix arrays.
For 10 of these genes there was at least one probe set that
detected differential expression in at least one of the investi-
gated tissues, and in three cases, the predicted allele prefer-
ence consistently agreed with the direction of change
detected by the probe sets (Supplementary Table S5).
DISCUSSION
Microarray measurements versus allele-specific assays
In principle, microarrays are an ideal tool for the large-scale
detection of imprinted genes in UpDp/UpD material because
imprinted genes are expected to exhibit an extreme expres-
sion differential between the matUpDp/UpD and patUpDp/
UpD samples. Empirically however, the array measurements
will lead to both false negatives and false positives due to,
among other factors, the sharing of probe sets between
multiple alternative transcripts, cross-hybridization and
downstream effects of the chromosome anomaly. Most
downstream targets can be excluded by map position.
Figure 4. Imprinting analysis in human placenta. For DHCR7 two distinct
polymorphisms, a G/A SNP at nucleotide 364 and a known T/C SNP at
nucleotide 382 (rs1790334) in the DHCR7 cDNA were identified in two
individuals by sequencing fetal DNA samples. For the AMPD3 analysis a T/A
SNP at nucleotide 3160 in the AMPD3 cDNA was identified in one individual
by sequencing fetal DNA samples. Allele-specific expression analysis in
matched placenta cDNA showed the genes to be biallelic.
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has been veriﬁed by allele-speciﬁc assay, its imprinting status
remains uncertain. Thus, the ﬁne-tuning of the true and espe-
cially the FPR in microarray data analysis is of paramount
importance in a screen, such as this and has been a focus
of this study.
Probe sets representing differentially expressed sequences
(juSLRj > .6) were present for 40 of the 59 genes that were
tested for imprinting using the UpDp and/or the SNP assay.
Nineteen transcripts were assayed based on past analyses
using outdated Affymetrix  software and annotation
(MAS4). For individual tissues, Table 4 shows the total num-
ber of transcripts for individual tissues that were tested using
an allele-speciﬁc assay and compares the results with the
microarray measurements. The control gene, H19, showed
robust maternal expression in the SNP assay (Figure 3). How-
ever, contrary to expectation, on examining the differential
expression on the embryo and placenta distal matUpDp versus
wt microarrays, H19 had similar expression levels in both
samples (Supplementary Table S1). In contrast, Igf2, was
expressed in wt and vastly reduced in matUpDp RNA as
would be predicted (Supplementary Table S1). The probe
sequences for H19 were examined but there was no evidence
for cross-hybridization in the Affymetrix  annotation. Since
H19 is a very highly expressed transcript in the cell, the ﬂuo-
rescent signal may have saturated, but this was not the case
because GCOS excludes saturated readings from the compara-
tive analysis, and for H19, all probes were included. Hence
this false negative result may be an artifactual problem, but
could also be due to a biological modulation of H19 RNA
levels in the matUpDp samples by an unknown mechanism.
More than 66% of the 40 genes with microarray evidence
for differential expression were found to be biallelic in the
UpDp and/or SNP assays (Table 4). This is in stark contrast
to the FPR of 5% that we estimated for our threshold for dif-
ferential expression (juSLRj > .6; Figure 1). However, this
estimate is with respect to differential expression detected
by a single probe set. Each of the tested 59 genes is on aver-
age represented by four probe sets that were each used for
measurements in at least two different tissues. Assuming
independence, the probability of one of these probe sets
detecting differential expression in one of the tissues by
chance is roughly one-third. However, only 9 of the
31 genes detected as differentially expressed by their probe
sets subsequently exhibited an allele preference in the
UpDp assay. For a per-gene and cross-tissue FPR of 1/3 the
expected number is 20. The UpDp assay is not strand-
speciﬁc, so an antisense transcript could mask an allele bias
in the UpDp assay, but this is unlikely to explain the
 50% shortfall in genes with an allele bias. The probe sets
that apparently mistakenly indicate differential expression
do not obviously share any characteristics that distinguish
them from ‘correct’ probe sets. So, a large fraction of the
inconsistencies between the microarray and the UpDp assay
results remain unexplained.
Limited overlap with previous whole genome
imprinting studies
Previous studies report that the genome-wide identiﬁcation of
imprinted genes via differential expression between partheno-
genotes and androgenotes likely suffers from a high FPR
Table 4. Contingency table summarizing Supplementary Table S2 by contrasting the microarray-derived mode of expression (either M ¼ maternal: uSLR > .6,
P ¼ paternal: uSLR <  .6 or B ¼ biallelic) with the mode determined by the UpDp/UpD PCR and/or SNP sequencing assays
Mode of expression based on microarray measurement
Array-based Maternal Paternal Biallelic
expression mode: l M P B M P B M P B
Tissue Total
Pl 13 2 29
Ampd3 Dhcr7
Tspan4 Th
Em 28 9 2 4 13
A330103N21Rik AK080843 Ebf3
Ccndl BB264453 Gabra5
Ceacam11-14 Hbxap
Cebpa Rtn4
Pank3
Teadl
Br 30 1 5 8 11 5
Gabral* Rkhd3 Inpp5f_v2 Ebf2
Rgs10 AK080843 Txnl2
MGI:2446326 BM117114 Mlstd2
Arrdc4 BB312372* Kcnq5
0710005119Rik BB264453* Dlgh2
BB182944 A1114950
BB077283 AA123443
AV328498 4933439C20Rik
4632427E13Rik
4632419K20Rik
2310047115Rik
Ht 2 1 1
Sh3gl3
For each combination of microarray-derived and assay-derived expression mode, the number of distinct genes that exhibited this combination is provided. Empty
entries correspond to zero occurrences. The gene names are given except for genes that showed a biallelic mode of expression in both the microarray and assay
experiments. New imprinted genes/transcripts are in bold. *indicates no SNP between Bb and Cast.
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partheno- and androgenesis (39,47). This is likely to explain
our limited overlap with the results of the RIKEN FANTOM2
imprinting study (46), especially since relaxing our threshold
for differential expression increased the overlap signiﬁcantly.
The small overlap between our results and the genes pre-
dicted to be imprinted in (6) has several possible explana-
tions. The predictor may have misclassiﬁed imprinted genes
for which the training set was not representative, e.g.
imprinted genes with a distinct regulatory mechanism that
would have made the sequence features appear atypical for
an imprinted gene. For a given gene prediction, it is still
unknown in which tissue(s) and developmental stages the
imprinting occurs. Our microarray measurements may not
have covered the relevant tissues or developmental stages.
A general difﬁculty in establishing a closer correspondence
between the classiﬁer and our microarray-based approach is
the classiﬁers’ limited applicability to characterized genes,
while the microarrays contain a large number of EST-
complementary probe sets.
Maternally expressed genes in placenta
Two of the three genes found to be maternally expressed in
the placenta, Dhcr7 and Th are located within or in close
association with the BWS orthologous region on mouse distal
Chr 7. The third, Ampd3, is not associated with the cluster
and maps  33 Mb centromeric of H19 in apparent isolation
from any other imprinted gene. The majority of genes con-
tained within the respective human and mouse BWS regions
are highly conserved, both in structural organization and,
with few exceptions, in imprinting status (48,49). We could
not address the imprinting status of TH in humans due to
the absence of informative polymorphisms in the available
tissues. DHCR7 and AMPD3 were biallelic in placenta, a
ﬁnding consistent with their respective locations on 11q13
and 11p15.4, neither region being associated with imprinting
(Figure 4).
The boundaries of the cluster have been deﬁned by the
maternally expressed H19 and Osbpl5 genes (48–50). The
ﬁnding of preferential maternal expression at Dhcr7, which
is located outside these arbitrary boundaries could extend
this region of imprinting. Current evidence supports regional
imprinting control in the BWS cluster by two imprinting cen-
tres (IC’s), the H19 differentially methylated domain (DMD)
(51,52), and the Kcnq1 (Kv) DMR1 (40,53). Paternal inheri-
tance of a KvDMR1 deletion leads to loss of imprinting of
several maternally expressed imprinted genes with disruption
of the repressive paternally expressed Kcnq1ot1 antisense
transcript thought to be responsible for this effect. Though
not formally addressed here, it is conceivable that the mater-
nal expression of Th and Dhcr7, both of which are located
adjacent to KvDMR1 could be regulated by this region, or
by the Kcnq1ot1 transcript in cis. Analysis of both genes
within the context of a KvDMR1 deletion allele could address
this expectation.
One of the limitations of examining monoallelic expression
in placenta compared to other organs is the presence of
invading maternal blood vessels. The allele-speciﬁc assay
in interspecies hybrids were performed on placenta with
the deciduum removed but the precise fetal:maternal
contribution is not known. Some maternal expression could
be derived from maternal contamination. The maternal and
paternal UPD placentae would not be susceptible to this
issue since it applies equally to these tissues harvested for
the arrays. Thus the arrays provide independent evidence
for differential expression. Maternal allele preference
observed in these genes is largely consistent with the direc-
tionality of imprinting of other known placental imprinted
genes, an exception provided by the Igf2 P0 transcript,
expressed exclusively from the paternal allele in labyrinthine
trophoblast (54,55).
While Ampd3 shows almost exclusive expression from
the maternal allele, for Dhcr7 and Th, transcription was also
evident (albeit at a much lower level) from the paternal allele,
which indicates that maternal expression of these genes may
not be absolute. On the other hand we note the caveat of alter-
native (non-imprinted) transcripts or imprinting in a cell
lineage-dependent manner that potentially complicates this
interpretation. However it has not escaped our notice that simi-
larly ‘incomplete’ imprinting has been observed for other
placenta-speciﬁc genes, Nap1l4, Phlda2 and Osbpl5,l o c a t e d
immediately centromeric to Dhcr7 (48,49). Incomplete silenc-
ing of the paternal allele in these examples, it has been argued,
reﬂects their relatively distant separation from the KvDMR1
compared with other genes, Kcnq1, Kcnq1ot1 and Cdkn1c,
that are more closely associated with this element and robustly
imprinted (49), providing a possible mechanistic explanation
for these observations.
Imprinted EST transcripts identified in the
PWS/Angelman Syndrome region
PWS is thought to arise as a consequence of the loss in
expression of several paternally expressed imprinted genes
on human 15q11–13. Studies of transgenic models have not
revealed an obvious candidate, though the Ndn gene, when
disrupted in mice, causes failure to thrive, a frequent observa-
tion in PWS (56). The characterization of additional
imprinted transcripts within this region could therefore con-
tribute to the further genetic dissection of PWS. Four novel
imprinted transcripts AK080843, BM117114, BB077283 and
AV328498 were identiﬁed in the PWS/AS orthologous region
on proximal Chr 7. Bioinformatic analysis did not reveal evi-
dence that these transcripts were contained within larger tran-
scription units or possessed a capacity for protein coding.
Signiﬁcantly, human orthologues could not be found for
two transcripts (BM117114 and BB077283), suggesting that
they do not have a role in PWS. For AK080843, a 100 bp
sequence shares 96% identity in the human genome although
extensive RT–PCR analysis failed to detect transcripts from
this region (T. R. Menheniott, unpublished data).
Unifying hypotheses to explain imprinting disorders will
require a comprehensive mapping of genes in the pertinent
critical regions. Methods permitting the global detection of
imprinted genes across multiple developmental lineages are
likely to shed light upon the role of imprinting processes in
such disorders. Indeed a prominent conclusion of this
study is that the total number of imprinted genes is likely
to exceed the number of currently known imprinted genes
and the incidence of tissue-speciﬁc imprinting will be
signiﬁcant.
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